Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 314

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection

Open access
Renna, Maurizio, Schaffner, Catherine, Brown, Karen, Shang, Shaobin, Tamayo, Marcela Henao, Hegyi, Krisztina, Grimsey, Neil J., Cusens, David, Coulter, Sarah, Cooper, Jason, Bowden, Anne R., Newton, Sandra M., Kampmann, Beate, Helm, Jennifer, Jones, Andrew, Haworth, Charles S., Basaraba, Randall J., DeGroote, Mary Ann, Ordway, Diane J., Rubinsztein, David C., Floto, R. Andres·2011·Journal of Clinical Investigation

Abstract

Azithromycin is a potent macrolide antibiotic with poorly understood antiinflammatory properties. Long-term use of azithromycin in patients with chronic inflammatory lung diseases, such as cystic fibrosis (CF), results in improved outcomes. Paradoxically, a recent study reported that azithromycin use in patients with CF is associated with increased infection with nontuberculous mycobacteria (NTM). Here, we confirm that long-term azithromycin use by adults with CF is associated with the development of infection with NTM, particularly the multi-drug-resistant species Mycobacterium abscessus, and identify an underlying mechanism. We found that in primary human macrophages, concentrations of azithromycin achieved during therapeutic dosing blocked autophagosome clearance by preventing lysosomal acidification, thereby impairing autophagic and phagosomal degradation. As a consequence, azithromycin treatment inhibited intracellular killing of mycobacteria within macrophages and resulted in chronic infection with NTM in mice. Our findings emphasize the essential role for autophagy in the host response to infection with NTM, reveal why chronic use of azithromycin may predispose to mycobacterial disease, and highlight the dangers of inadvertent pharmacological blockade of autophagy in patients at risk of infection with drug-resistant pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci46095

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 314

Metadata

Authors
Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M. H., Hegyi, K., Grimsey, N. J., Cusens, D., Coulter, S., Cooper, J., Bowden, A. R., Newton, S. M., Kampmann, B., Helm, J., Jones, A., Haworth, C. S., Basaraba, R. J., DeGroote, M. A., Ordway, D. J., Rubinsztein, D. C., & Floto, R. A.
Venue
Journal of Clinical Investigation
Published
2011-09-01
Volume
121
Issue
9
Pages
3554-3563
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2016283787
Cited by
314
References
31
FWCI
18.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. https://app.cochat.ai/papers/10.1172/jci46095
The paper
Renna, M., Schaffner, C., Brown, K., Shang, S., Tamayo, M. H., Hegyi, K., Grimsey, N. J., Cusens, D., Coulter, S., Cooper, J., Bowden, A. R., Newton, S. M., Kampmann, B., Helm, J., Jones, A., Haworth, C. S., Basaraba, R. J., DeGroote, M. A., Ordway, D. J., . . . Floto, R. A. (2011). Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. Journal of Clinical Investigation. https://doi.org/10.1172/jci46095

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.